The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
The Innate Immune Response to Adenovirus Vectors
Abstract
Gene therapy is a clinical strategy that may potentially treat an array of genetic and nongenetic diseases, as well as a novel method for drug delivery and vaccination. To these ends, adenovirus vectors are a promising means to deliver specific genes of interest into the patient. A major limitation of the use of adenovirus vectors is the host immune response. Adenovirus vectors induce the innate arm of the immune system that results in inflammation of transduced tissues and efficient clearance of administered vectors. Unlike adaptive immunity, the innate response is mediated by the adenovirus particle and does not require viral transcription. In vivo, the innate immune response involves the induction of cytokines and activation of effector leukocytes that comprise the host response to these agents. A number of interactions with leukocytes and with epithelial and endothelial cells are essential in triggering the host response to adenovirus vectors. Signal transduction via MAP kinases and NF-kappaB-mediated gene transcription are triggered during early virus-cell interactions and are key events in the innate recognition of adenovirus vector transduction. This review aims to describe data examining cellular and molecular mechanisms involved in the adenovirus-mediated innate immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5
Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt-Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L., & Finberg, R. W. (1997) · Science · doi:10.1126/science.275.5304.1320 · Cited by 3,102
Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment
Wickham, T. J., Mathias, P., Cheresh, D. A., & Nemerow, G. R. (1993) · Cell · doi:10.1016/0092-8674(93)90231-e · Cited by 2,199
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
Kay, M. A., Glorioso, J. C., & Naldini, L. (2001) · Nature Medicine · doi:10.1038/83324 · Cited by 1,342
NODs: intracellular proteins involved in inflammation and apoptosis
Inohara, N., & Nuñez, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1086 · Cited by 1,064
Noncytolytic Control of Viral Infections by the Innate and Adaptive ImmuneResponse
Guidotti, L. G., & Chisari, F. V. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.65 · Cited by 996
Crystal, R. G., McElvaney, N. G., Rosenfeld, M. A., Chu, C.-S., Mastrangeli, A., Hay, J. G., Brody, S. L., Jaffe, H. A., Eissa, N. T., & Danel, C. (1994) · Nature Genetics · doi:10.1038/ng0994-42 · Cited by 826
Parks, R. J., Chen, L., Anton, M., Sankar, U., Rudnicki, M. A., & Graham, F. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13565 · Cited by 725
Roelvink, P. W., Lizonova, A., Lee, J. G. M., Li, Y., Bergelson, J. M., Finberg, R. W., Brough, D. E., Kovesdi, I., & Wickham, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.7909-7915.1998 · Cited by 654
Zhang, S., Han, J., Sells, M. A., Chernoff, J., Knaus, U. G., Ulevitch, R. J., & Bokoch, G. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.23934 · Cited by 614
Knowles, M. R., Hohneker, K. W., Zhou, Z., Olsen, J. C., Noah, T. L., Hu, P.-C., Leigh, M. W., Engelhardt, J. F., Edwards, L. J., Jones, K. R., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331302 · Cited by 566
Innate Immune Mechanisms Dominate Elimination of Adenoviral Vectors Following In Vivo Administration
Worgall, S., Wolff, G., Falck-Pedersen, E., & Crystal, R. G. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.1-37 · Cited by 491
Adenoviruses as Gene-Delivery Vehicles
Wilson, J. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341809 · Cited by 476
Induction and Regulation of IFNs During Viral Infections
Malmgaard, L. (2004) · Journal of Interferon & Cytokine Research · doi:10.1089/1079990041689665 · Cited by 454
Muruve, D. A., Barnes, M. J., Stillman, I. E., & Libermann, T. A. (1999) · Human Gene Therapy · doi:10.1089/10430349950018364 · Cited by 447
Self-citationLieber, A., He, C. Y., Meuse, L., Schowalter, D., Kirillova, I., Winther, B., & Kay, M. A. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8798-8807.1997 · Cited by 412
Roelvink, P. W., Lee, G. M., Einfeld, D. A., Kovesdi, I., & Wickham, T. J. (1999) · Science · doi:10.1126/science.286.5444.1568 · Cited by 406
Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs
Krieg, A. M., Wu, T., Weeratna, R., Efler, S. M., Love-Homan, L., Yang, L., Yi, A.-K., Short, D., & Davis, H. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12631 · Cited by 397
Zhang, Y., Chirmule, N., Gao, G.-P., Qian, R., Croyle, M., Joshi, B., Tazelaar, J., & Wilson, J. M. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0329 · Cited by 376
Raper, S. E., Yudkoff, M., Chirmule, N., Gao, G.-P., Nunes, F., Haskal, Z. J., Furth, E. E., Propert, K. J., Robinson, M. B., Magosin, S., et al. (2002) · Human Gene Therapy · doi:10.1089/10430340152712719 · Cited by 354
Schnell, M. A., Zhang, Y., Tazelaar, J., Gao, G.-P., Yu, Q. C., Qian, R., Chen, S.-J., Varnavski, A. N., LeClair, C., Raper, S. E., et al. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0330 · Cited by 342
Role of α v Integrins in Adenovirus Cell Entry and Gene Delivery
Nemerow, G. R., & Stewart, P. L. (1999) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.63.3.725-734.1999 · Cited by 270
Innate Sensing of Viruses by Toll-Like Receptors
Boehme, K. W., & Compton, T. (2004) · Journal of Virology · doi:10.1128/jvi.78.15.7867-7873.2004 · Cited by 265
Yang, Y., Xiang, Z., Ertl, H. C., & Wilson, J. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7257 · Cited by 260
Brunetti-Pierri, N., Palmer, D. J., Beaudet, A. L., Carey, K. D., Finegold, M., & Ng, P. (2004) · Human Gene Therapy · doi:10.1089/10430340460732445 · Cited by 256
The NKT cell system: bridging innate and acquired immunity
Taniguchi, M., Seino, K.-I., & Nakayama, T. (2003) · Nature Immunology · doi:10.1038/ni1203-1164 · Cited by 256
Adenovirus Endocytosis via α v Integrins Requires Phosphoinositide-3-OH Kinase
Li, E., Stupack, D., Klemke, R., Cheresh, D. A., & Nemerow, G. R. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2055-2061.1998 · Cited by 250
Complexity and specificity of integrin signalling
Giancotti, F. G. (2000) · Nature Cell Biology · doi:10.1038/71397 · Cited by 246
Kafri, T., Morgan, D., Krahl, T., Sarvetnick, N., Sherman, L., & Verma, I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11377 · Cited by 244
Huang, S., Kamata, T., Takada, Y., Ruggeri, Z. M., & Nemerow, G. R. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4502-4508.1996 · Cited by 237
Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression
Bruder, J. T., & Kovesdi, I. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.398-404.1997 · Cited by 232
Croyle, M. A., Chirmule, N., Zhang, Y., & Wilson, J. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.10.4792-4801.2001 · Cited by 229
Adenovirus-activated PKA and p38/MAPK pathways boost microtubule-mediated nuclear targeting of virus
Suomalainen, M., Nakano, M. Y., Boucke, K., Keller, S., & Greber, U. F. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1310 · Cited by 223
Hidaka, C., Milano, E., Leopold, P. L., Bergelson, J. M., Hackett, N. R., Finberg, R. W., Wickham, T. J., Kovesdi, I., Roelvink, P., & Crystal, R. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5309 · Cited by 216
Einfeld, D. A., Schroeder, R., Roelvink, P. W., Lizonova, A., King, C. R., Kovesdi, I., & Wickham, T. J. (2001) · Journal of Virology · doi:10.1128/jvi.75.23.11284-11291.2001 · Cited by 213
Muruve, D. A., Cotter, M. J., Zaiss, A. K., White, L. R., Liu, Q., Chan, T., Clark, S. A., Ross, P. J., Meulenbroek, R. A., Maelandsmo, G. M., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5966-5972.2004 · Cited by 201
Self-citationIntracellular vs extracellular recognition of pathogens – common concepts in mammals and flies
Girardin, S. E., Sansonetti, P. J., & Philpott, D. J. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02334-x · Cited by 190
Greber, U. F. (2002) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-002-8453-3 · Cited by 186
Yei, S., Mittereder, N., Wert, S., Whitsett, J. A., Wilmott, R. W., & Trapnell, B. C. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.6-731 · Cited by 172
Thomas, C. E., Birkett, D., Anozie, I., Castro, M. G., & Lowenstein, P. R. (2001) · Molecular Therapy · doi:10.1006/mthe.2000.0224 · Cited by 172
Adenovirus Hexon Protein Is a Potent Adjuvant for Activation of a Cellular Immune Response
Molinier-Frenkel, V., Lengagne, R., Gaden, F., Hong, S.-S., Choppin, J., Gahery-Ségard, H., Boulanger, P., & Guillet, J.-G. (2002) · Journal of Virology · doi:10.1128/jvi.76.1.127-135.2002 · Cited by 165
Elimination, blocking, and activation of macrophages: three of a kind?
van Rooijen, N., & Sanders, A. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.6.702 · Cited by 162
Zsengellér, Z. K., Otake, K., Hossain, S.-A., Berclaz, P., & Trapnell, B. C. (2000) · Journal of Virology · doi:10.1128/jvi.74.20.9655-9667.2000 · Cited by 156
The Role of Capsid–Endothelial Interactions in the Innate Immune Response to Adenovirus Vectors
Liu, Q., Zaiss, A. K., Colarusso, P., Patel, K. D., Haljan, G. J., Wickham, T. J., & Muruve, D. A. (2003) · Human Gene Therapy · doi:10.1089/104303403321618146 · Cited by 154
Self-citationLiu, Z., Govindarajan, S., Okamoto, S., & Dennert, G. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6480 · Cited by 149
Borgland, S. L., Bowen, G. P., Wong, N. C. W., Libermann, T. A., & Muruve, D. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.3941-3947.2000 · Cited by 146
Self-citationOtake, K., Ennist, D. L., Harrod, K. S., & Trapnell, B. C. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.15-2207 · Cited by 144
Tibbles, L. A., Spurrell, J. C. L., Bowen, G. P., Liu, Q., Lam, M., Zaiss, A. K., Robbins, S. M., Hollenberg, M. D., Wickham, T. J., & Muruve, D. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.4.1559-1568.2002 · Cited by 141
Self-citationTumor necrosis factor α plays a central role in immune-mediated clearance of adenoviral vectors
Elkon, K. B., Liu, C.-C., Gall, J. G. D., Trevejo, J., Marino, M. W., Abrahamsen, K. A., Song, X., Zhou, J.-L., Old, L. J., Crystal, R. G., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9814 · Cited by 133
Smith, T. A., Idamakanti, N., Kylefjord, H., Rollence, M. L., King, L., Kaloss, M., Kaleko, M., & Stevenson, S. C. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0613 · Cited by 130
Reich, N. C., Pine, R. I., Levy, D. E., & Darnell, J. E., Jr. (1988) · Journal of Virology · doi:10.1128/jvi.62.1.114-119.1988 · Cited by 125
Philpott, N. J., Nociari, M., Elkon, K. B., & Falck-Pedersen, E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308368101 · Cited by 122
Higginbotham, J. N., Seth, P. K., Blaese, R. M., & Ramsey, W. J. (2002) · Human Gene Therapy · doi:10.1089/10430340152712683 · Cited by 117
Transient suppression of macrophage functions by liposome-encapsulated drugs
van Rooijen, N., Bakker, J., & Sanders, N. (1997) · Trends in biotechnology · doi:10.1016/s0167-7799(97)01019-6 · Cited by 116
Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene.
Gutch, M. J., & Reich, N. C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.18.7913 · Cited by 106
Pulmonary Inflammation Induced by Incomplete or Inactivated Adenoviral Particles
McCoy, R. D., Davidson, B. L., Roessler, B. J., Huffnagle, G. B., Janich, S. L., Laing, T., & Simon, R. H. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.12-1553 · Cited by 104
Bowen, G. P., Borgland, S. L., Lam, M., Libermann, T. A., Wong, N. C. W., & Muruve, D. A. (2002) · Human Gene Therapy · doi:10.1089/10430340252792503 · Cited by 96
Self-citationKuz'min, A. N., Finegold, M. J., & Eisensmith, R. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300377 · Cited by 94
Sung, R. S., Qin, L., & Bromberg, J. S. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0318 · Cited by 83
Toll-like receptors and innate antiviral responses
Vaidya, S. A., & Cheng, G. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00070-0 · Cited by 70
High adenoviral loads stimulate NFκB-dependent gene expression in human vascular smooth muscle cells
Clesham, G., Adam, P., Proudfoot, D., Flynn, P., Efstathiou, S., & Weissberg, P. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300576 · Cited by 66
Roth, M. D., Cheng, Q., Harui, A., Basak, S. K., Mitani, K., Low, T. A., & Kiertscher, S. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4651 · Cited by 66
Amin, R. S., Wilmott, R. W., Schwarz, Y., Trapnell, B. C., & Stark, J. M. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.2-145 · Cited by 64
Stilwell, J. L., McCarty, D. M., Negishi, A., Superfine, R., & Samulski, R. J. (2003) · Journal of Virology · doi:10.1128/jvi.77.23.12881-12885.2003 · Cited by 63
Benihoud, K., Saggio, I., Opolon, P., et al. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9514-9525.1998 · Cited by 59
Jefferies, W. A., & Burgert, H.-G. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.6.1653 · Cited by 46
Peng, Y., Falck-Pedersen, E., & Elkon, K. B. (2001) · Journal of Virology · doi:10.1128/jvi.75.10.4540-4550.2001 · Cited by 44
Ruzek, M. C., Kavanagh, B. F., Scaria, A., Richards, S. M., & Garman, R. D. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0529 · Cited by 42
The role of selectins and integrins in adenovirus vector-induced neutrophil recruitment to the liver
Li, Y., Muruve, D. A., Collins, R. G., Lee, S. S., & Kubes, P. (2002) · European Journal of Immunology · Cited by 38
Self-citationE1A and E1B proteins inhibit inflammation induced by adenovirus
Schaack, J. B., Bennett, M. L., Colbert, J. D., Torres, A. V., Clayton, G. H., Ornelles, D. A., & Moorhead, J. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0303709101 · Cited by 36
Rafii, S., Dias, S., Meeus, S., Hattori, K., Ramachandran, R., Feuerback, F., Worgall, S., Hackett, N. R., & Crystal, R. G. (2001) · Circulation Research · doi:10.1161/hh0901.089884 · Cited by 31
Stark, J. M., Amin, R. S., & Trapnell, B. C. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.14-1669 · Cited by 28
Cited by
Viral vector platforms within the gene therapy landscape
Bulcha, J. T., Wang, Y., Ma, H., Tai, P. W. L., & Gao, G. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00487-6 · Cited by 1,404
Adenovirus vectors for gene therapy, vaccination and cancer gene therapy
Wold, W., & Toth, K. (2014) · Current Gene Therapy · doi:10.2174/1566523213666131125095046 · Cited by 555
Base editing: advances and therapeutic opportunities
Porto, E. M., Komor, A. C., Slaymaker, I. M., & Yeo, G. W. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0084-6 · Cited by 476
Adenoviruses: update on structure and function
Russell, W. C. (2009) · Journal of General Virology · doi:10.1099/vir.0.003087-0 · Cited by 461
Bioconjugated silica nanoparticles: Development and applications
Wang, L., Zhao, W., & Tan, W. (2008) · Nano Research · doi:10.1007/s12274-008-8018-3 · Cited by 378
Metadata
- Authors
- Muruve, D. A.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 2004-12
- Volume
- 15
- Issue
- 12
- Pages
- 1157-1166
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W2040837189
- Cited by
- 407
- References
- 71
- FWCI
- 15.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.